Docking based design of diastereoisomeric MTCA as GPIIb/IIIa receptor inhibitor.
Wang X, Wang Y, Wu J, Gui L, Zhang X, Zheng M, Wang Y, Zhao S, Li Z, Zhao M, Peng S.
Wang X, et al. Among authors: peng s.
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5114-5118. doi: 10.1016/j.bmcl.2017.10.068. Epub 2017 Oct 28.
Bioorg Med Chem Lett. 2017.
PMID: 29108753